Navigation Links
GW Pharmaceuticals to Report 2013 Q4 and Full Year Financial Results and Host Conference Call on 19 November, 2013
Date:11/12/2013

LONDON, Nov. 12, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 19 November 2013 its fourth quarter and full year financial results for the period ending 30 September, 2013. GW will also host a conference call the same day at 1:00 p.m. GMT (8:00 a.m. EST).

Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company's website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 22 countries. Sativex is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW has established a world leading position in the development of plant-derived cannabinoid therapeutics and has a deep pipeline of additional clinical-stage cannabinoid product candidates targeting epilepsy (including an orphan pediatric epilepsy program), type 2 diabetes, ulcerative colitis, glioma and schizophrenia. For further information, please visit www.gwpharm.com.


'/>"/>
SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rafarma Pharmaceuticals, Inc. (RAFA) Joins in Economic Development Coalition to Increase Biotech Growth in Terbuny, Russia.
2. DelMar Pharmaceuticals Gives Quarterly Shareholder Update
3. Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
4. Stason Pharmaceuticals Inc. announces Kansas City expansion, adds human health capabilities
5. Imprimis Pharmaceuticals, Inc. Announces Its Attendance at the American Academy of Ophthalmology in New Orleans, Nov. 16-19
6. ProVen Pharmaceuticals Participates in the Dolphins Cycling Challenge
7. Panacea Pharmaceuticals Presents Three Papers Regarding Its Nanoparticle-Based Therapeutic Cancer Vaccine at the Society for Immunotherapy of Cancer Annual Meeting at National Harbor, MD
8. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
9. ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
10. Vanda Pharmaceuticals Reports Third Quarter 2013 Results
11. Questcor Pharmaceuticals to Present at the 2013 Credit Suisse Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... May 31, 2016 The global ... progressing at a CAGR of 10.6% within a forecast ... at US$0.46 bn in 2013. Owing to favorable factors ... reach US$0.88 bn by the end of this forecast ... the market,s holistic representation in a research report published ...
(Date:5/31/2016)... , May 31, 2016 CollPlant Ltd. (TASE: ... rhCollagen technology for tissue repair products - announces that ... Israel,s Ministry of Economy, for ... project for 2016. The Chief Scientist,s grant amount to NIS ... which totaled NIS 4.7 million.  The development ...
(Date:5/30/2016)... 2016 According to ... Market by Technology (Single-factor (Fingerprint, Face, Iris, ... (Workforce Management), End User (Hospitals, Healthcare Institutions) ... MarketsandMarkets, the market is projected to reach ... 1,182.6 Million by 2016, at a CAGR ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... Secura Consultants ... Louis, Missouri from July 21-23 at the Spazio Westport. The conference is a ... Group financial advisers who work primarily with physicians and professionals in the medical ...
(Date:5/31/2016)... ... 31, 2016 , ... "ProDrop 3D Abstract will spark new innovative ideas for ... Austin - CEO of Pixel Film Studios. , Create an abstract backdrop animation ... ability to generate and manipulate three-dimensional shapes with ease all within Final Cut Pro ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... RF Safe's ... provide the best accessories to avoid excessive Smartphone radiation implicated in the most recent ... released on the bioRxiv preprint server on May 26th (PDF) by the ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... characteristics and the physical and behavioral worlds in which they live, functions ... medicine, diagnosing an individual’s disease depends on accurately assessing his or her ...
(Date:5/31/2016)... ... 2016 , ... Presence Technology , a multi-channel provider ... Gartner, Inc. in the Contact Center Infrastructure Magic Quadrant (*). , Gartner’s May ... of which include: Computer-telephony integration (CTI)/Web services interfaces, Tools for integration with ...
Breaking Medicine News(10 mins):